Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia

American Journal of Hematology
Lucie Opatrny, Margaret N Warner

Abstract

Heparin-induced thrombocytopenia (HIT) is a common immunological drug reaction. After exposure to heparin, some patients develop heparin dependent antibodies with no evidence of thrombosis, while others are at risk of thrombocytopenia, thrombosis, limb loss, and death. We conducted a retrospective chart review on all patients serologically positive for HIT by HPIA ELISA in a single tertiary-care hospital, to determine whether patients with malignancy had an increased risk of thrombotic complications. Medical records of 55 patients who tested positive for HIT and met clinical criteria for HIT were analyzed. All patients had been treated with unfractionated heparin. Malignancy was diagnosed in 11 patients, either at surgery or post-mortem examination. A higher rate of venous thrombosis and pulmonary embolism was observed in patients with HIT and malignant disease when compared to patients with no underlying malignancy (odds ratio 13.6, 95% CI 2.9-63.8).

References

Jun 1, 1993·British Journal of Haematology·L K BoshkovJ G Kelton
Feb 12, 1998·Annals of Internal Medicine·T E WarkentinJ G Kelton
Sep 18, 2002·Cancer Treatment Reviews·Agnes Y Lee

❮ Previous
Next ❯

Citations

Sep 8, 2007·Postgraduate Medical Journal·I AhmedR Powell
Aug 16, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Philippe DebourdeauDominique Farge
Aug 1, 2009·Clinical Journal of Gastroenterology·Masato Sakon, Masataka Ikeda
May 22, 2010·Hematology/oncology Clinics of North America·Thomas G DeLoughery
Aug 4, 2009·Emergency Medicine Clinics of North America·Thomas G DeLoughery
May 5, 2009·Thrombosis Research·Ismail ElalamyUNKNOWN GEHT HIT Study Group
Nov 21, 2007·Thrombosis Research·Paolo PrandoniAndrea Piccioli
Jan 30, 2007·Hematology/oncology Clinics of North America·Jerrold H Levy, Marcie J Hursting
Mar 27, 2007·Pharmacotherapy·William E DagerMaureen A Smythe
Mar 18, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Emily Z T Mathews
Jan 28, 2010·American Journal of Surgery·Sandra BattistelliTommaso Gori
May 26, 2017·Pharmacoepidemiology and Drug Safety·Juliane BolbrinkerReinhold Kreutz
Dec 20, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Schuharazad AbroMarcus Quek
Mar 16, 2007·The Annals of Pharmacotherapy·Alexandre ChanWilliam E Dager
May 25, 2005·Circulation·Ik-Kyung Jang, Marcie J Hursting
Apr 28, 2005·Expert Review of Cardiovascular Therapy·Peter A Kouides, William Fricke
Dec 26, 2006·Expert Review of Cardiovascular Therapy·Bruce E Lewis, Marcie J Hursting
Aug 8, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·John G KeltonBruce E Lewis
Sep 3, 2013·Expert Review of Hematology·Radhika DasararajuAmitkumar Mehta
Jul 6, 2017·Journal of Thrombosis and Thrombolysis·Myra WongCristhiam M Rojas-Hernandez
Jan 1, 2014·SAGE Open Medical Case Reports·Weixin WuSai-Ching J Yeung
Nov 20, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Nathan VisweshwarBenjamin Djulbegovic
Feb 15, 2021·Journal of Thrombosis and Thrombolysis·Chieh Min Benjamin LaiAgnes Yuet Ying Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.